written by reader immunotherapy company

By bobmc100, January 29, 2021

What is the small cap company being pitched by Ian King. Says its a $409 Million company that recently received FDA approval for the treatment of respiratory inflammation in coviid patients.

This is a discussion topic or guest posting submitted by a Stock Gumshoe reader. The content has not been edited or reviewed by Stock Gumshoe, and any opinions expressed are those of the author alone.



This site uses Akismet to reduce spam. Learn how your comment data is processed.

1 Comment
Inline Feedbacks
View all comments
February 21, 2021 8:15 pm

Ampion, AMPE is a company working on FDA approval for their drug. Don’t think they’ve actually received FDA final approval yet…
In trials in both the US and Israel with good results to date. They are doing trials on an injectable and a nebulized delivery (inhaler)

Add a Topic
Add a Topic

We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.

More Info